MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/1759-7714.15403

Медицинская библиотека · Thoracic cancer · 2024

Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.

Doshita Kosei, Naito Tateaki, Matsuda Suguru, Morita Meiko, Sekikawa Motoki, Miura Keita, Kodama Hiroaki, Yabe Michitoshi, Morikawa Noboru, Iida Yuko, Mamesaya Nobuaki, Kobayashi Haruki, Ko Ryo, Wakuda Kazushige, Ono Akira, Murakami Haruyasu, Kenmotsu Hirotsugu, Takahashi Toshiaki

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Chemotherapy-induced anorexia is a common occurrence in patients undergoing treatment for advanced lung cancer. However, the relationship between chemotherapy-induced anorexia and weight loss during platinum-based chemotherapy combined with immune checkpoint inhibitors is unclear. This study explored the relationship between chemotherapy-induced anorexia and therapeutic outcomes in patients with stage IV non-small-cell lung cancer undergoing platinum-based chemotherapy combined with immune checkpoint inhibitors.

METHODS

The study retrospectively reviewed the medical records of 106 patients with stage IV non-small-cell lung cancer treated with platinum-based chemotherapy and immune checkpoint inhibitors between January 2019 and October 2022. The incidence of weight loss and its association with treatment efficacy was assessed in the chemotherapy-induced anorexia group. Chemotherapy-induced anorexia, nausea, and vomiting were evaluated using Common Terminology Criteria for Adverse Events v 5.0. Progression-free and overall survival were used to measure treatment efficacy.

RESULTS

Chemotherapy-induced anorexia was observed in 13.2% of patients. These patients exhibited significant weight loss at 6 and 9 weeks after treatment initiation compared to those in the non-chemotherapy-induced anorexia group. Progression-free and overall survival were shorter in the chemotherapy-induced anorexia group than in the non-chemotherapy-induced anorexia group, but the difference was not statistically significant.

CONCLUSIONS

Chemotherapy-induced anorexia was associated with significant weight loss and reduced treatment efficacy in patients with stage IV non-small-cell lung cancer. These results highlight the importance of implementing robust supportive care for chemotherapy-induced anorexia to mitigate weight loss and uphold treatment effectiveness during platinum-based chemotherapy combined with immune checkpoint inhibitors.

Для цитирования: Doshita Kosei, Naito Tateaki, Matsuda Suguru, Morita Meiko, Sekikawa Motoki, Miura Keita, Kodama Hiroaki, Yabe Michitoshi, Morikawa Noboru, Iida Yuko, Mamesaya Nobuaki, Kobayashi Haruki, Ko Ryo, Wakuda Kazushige, Ono Akira, Murakami Haruyasu, Kenmotsu Hirotsugu, Takahashi Toshiaki. Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.. Thoracic cancer. 2024. DOI: 10.1111/1759-7714.15403.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.